2012 Annual Meeting in Tampa, FL, April 29-May 2
Personalized Medicine in Depression
Though depression is one of the most prevalent mental illnesses that psychiatric practitioners will face, response to treatment is variable and largely unpredictable. During this session, Dr. Madhukar Trivedi, MD will identify characteristics which may predict treatment response. He will also highlight ways to “personalize” the treatment of depression to an individual. Lastly, Dr. Trivedi will highlight current and future research that focuses on identifying specific predictors of treatment response, such as biomarkers, genes or neuroimaging.
2002 Annual Meeting Sponsors
CPNP thanks the following sponsors of our 2002 Annual Meeting:
Platinum Level Sponsors
Gold Level Sponsors
Silver Level Sponsors
Contributors
Industry Symposia
Printable Version of Industry Symposia
The Cardiovascular Safety of Antipsychotic Drugs: Straight from the Heart
Thursday, April 18th, Sheraton Hotel Cirrus Ballroom
7:00 - 8:00 p.m. Dinner and Reception
7:30 - 9:00 p.m. Program:
Speakers:
Larry Ereshefsky, Pharm.D.
Dan Zimbroff, M.D.
-
Challenges in Treating Patients with Schizophrenia, and
Psychopharmacological Distinctions Amongst Antipsychotic Therapies - A Clinical Review of Atypical vs. Conventionals. Comparing Benefits and Risks.
- Changes in Cardiovascular Health Status: Pharmacological Mechanisms and Consequences of Antipsychotic Therapy.
- Differential Effects of Antipsychotics on Risk for Obesity, Hyperlipidemia, Glucose dysregulation and Cardiovascular Risk.
- Atypical Antipsychotics and the QTc Interval: WhereÕs the Beef?
- Managing the Cardiovascular Risks of Antipyschotics: The ÔHeartÕ of the matter.
 |
2 contact hours of ACPE credit provided by University of Texas |
Current Issues in the Use of Atypical Antipsychotics
Friday, April 19th, Sheraton Hotel and Grand Ballroom
6:00 - 8:15 a.m. Poster Session and Breakfast
Faculty:
Sheila Botts, Pharm.D.
C. Lindsay DeVane, Pharm.D.
Gary Levin, Pharm.D.
Melody Ryan, Pharm.D.
- Participants will view six topical posters while discussing issues with expert faculty.
|
|
Upon completion of a posttest, participants will be awarded 1 ACPE contact hour through CE Concepts. This posttest can be completed anytime during Symposium hours. |
Registration: Pre-registration online is suggested but not required.
|
|
 |
The Challenge of Drug-Drug Interactions
Saturday, April 20th, Sheraton Hotel and Grand Ballroom
6:00 - 6:45 a.m. Registration and Buffet Breakfast
6:45 - 8:15 a.m. Program:
Speaker:
Sheldon H. Preskorn, M.D.
-
This presentation addresses pharmacodynamic and pharmacokinetic considerations when using more than
one drug in combination
|
|
1.5 contact hours of ACPE credit provided by University of Texas |
|
|
|
Thinking Differently about Long Term Antipsychotic Therapy
Saturday, April 20th, Sheraton Hotel and Grand Ballroom
6:30 - 7:00 p.m. Reception
7:00 -10:00 p.m. Dinner and Program:
Speakers:
Larry Ereshefsky, Pharm.D.
Johnathan Lacro, Pharm.D.
- This program will focus on the history of depot antipsychotic therapy and the pharmcokinetic profile of risperidone long-acting injection along with compliance issues, short term trials and long term efficacy and safety of risperidone long-acting injection.
|
|
2 contact hours of ACPE credit provided by University of Texas |